Clinical Trials Directory

Trials / Completed

CompletedNCT04491409

Perioperative Care in the Cancer Patient -1, ARCA-1 Study

ARCA-1 Study: Perioperative Care in the Cancer Patient -1

Status
Completed
Phase
Study type
Observational
Enrollment
229 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study investigates the association of blood transfusions given around the time of surgery (perioperative) with complications after surgery (postoperative), cancer progression, and mortality after major oncologic non-cardiac surgery. The administration of blood products is an important clinical therapy to treat life-threatening blood (hematological) disorders (i.e. anemia, coagulation disorders or thrombocytopenia) in patients with cancer undergoing major non-cardiac surgery. On the other hand, the unnecessary exposure of those patients to blood products can be associated with the occurrence of unwanted severe complications and potentially increase the risk of death. An accurate understanding of the short and long-term outcomes, the patterns of blood transfusions, and the triggers of blood product administration may help researchers design and test the safety of perioperative blood transfusions in patients with cancer.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate if perioperative blood transfusions are associated with 1-year mortality. SECONDARY OBJECTIVES: I. To evaluate the association of blood transfusion with postoperative complications, 30 days mortality and cancer progression after major oncologic non-cardiac surgery. II. To gain knowledge on prevalence and patterns of blood product administration worldwide, the incidence and management of perioperative anemia and the incidence and treatment of perioperative coagulopathies. OUTLINE: Patients undergo standard of care treatment and their medical records are reviewed at 30 days and at 1 year after surgery.

Conditions

Interventions

TypeNameDescription
OTHERBest PracticeUndergo standard of care
OTHERMedical Chart ReviewMedical charts reviewed

Timeline

Start date
2020-08-03
Primary completion
2023-11-17
Completion
2023-11-17
First posted
2020-07-29
Last updated
2023-11-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04491409. Inclusion in this directory is not an endorsement.